Related Experiment Video
Updated: May 3, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Metabolic modulation: Pneumocystis phosphoglucomutase is a target influencing host recognition
Theodore J Kottom1, Eva M Carmona1, Bernd Lepenies2,3
1Thoracic Diseases Research Unit, Departments of Medicine and Biochemistry, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Phosphoglucomutase (PGM) is vital for fungal mannoprotein formation in Pneumocystis. Inhibiting PGM may offer a broad therapeutic strategy against fungal infections.
Area of Science:
- Biochemistry
- Mycology
- Molecular Biology
Background:
- Mannoproteins on the fungal surface are crucial for host-pathogen interactions.
- The phosphoglucomutase (PGM) enzyme's role in Pneumocystis mannoprotein synthesis is not well understood.
Purpose of the Study:
- To investigate the function of phosphoglucomutase (PGM) in Pneumocystis spp.
- To explore the role of PGM in fungal cell wall mannoprotein formation.
- To assess the potential of PGM as a therapeutic target.
Main Methods:
- Expressing the Pneumocystis murina Pmpgm2 gene in a Saccharomyces cerevisiae pgm2Δ mutant strain.
- Assessing mannose receptor (MR) binding and macrophage interaction.
- Utilizing Gas Chromatography-Mass Spectroscopy (GC-MS) to quantify mannose content.
Main Results:
- Complementation of the S. cerevisiae pgm2Δ strain with Pmpgm2 restored MR and macrophage binding to wild-type levels.
- GC-MS analysis revealed reduced mannose content in the pgm2Δ yeast strain.
- The study highlights PGM's role in dolichol glucosyl phosphate biosynthesis for cell wall integrity.
Conclusions:
- Fungal PGM is essential for proper mannoprotein formation and cell wall biosynthesis.
- Conserved targetable cysteine residues in PGM across fungal pathogens suggest potential for broad-spectrum therapeutic strategies.
- PGM inhibition presents a promising avenue for developing new antifungal treatments.
Related Concept Videos
Regulation of Metabolism
Pneumonia II: Pathophysiology
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
Cytomegalovirus Disease

